unknown
Stage
1
Investors
About
Zora Biosciences is a Finland-based diagnostic company that uses mass spectrometry to identify lipid biomarkers and develop high-throughput clinical tests for cardiometabolic diseases, including the CERT2 ceramide-based cardiovascular risk score and the dSCORE for type 2 diabetes. Tests are commercialized with international partners and via the company's reference laboratory in Finland.
Explore Zora Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.